Manmohan Agrawal, Pushpadi Cancer Care Centre, India
The prognosis of breast cancer remains unpredictable despite of frequent change in treatment protocol since last few decades. As we understand the heterogenous nature of the disease, complex tumor biology etc. the treatment protocols have changed. There is an unprecedented transf [....] » Read More

Title : Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Hepatocellular carcinoma is one of the most lethal malignancies for humans. Assessing the clinical outcomes of HCC remains challenging. In this study, a panel of 20 fusion genes in 200 hepatocellular carcinoma (HCC) samples was analyzed to predict the recurrence and survival rate [....] » Read More
Title : A case of papillary ductal carcinoma in situ coexisting with mucinous carcinoma of micro-papillary structure of the breast: A pathologic consideration of tumour microenvironment
Shinya Tajima, National Hospital Organization Shizuoka Medical Centre, Japan
We would like to present a only case study: However, our important findings might lead to help the interpretations of “tumour microenvironment (TME)”. We herein presenting about 70-year-old female. She presented with a palpable mass in the upper inner quadrant of t [....] » Read More
Title : Personalized oncology via precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ [....] » Read More
Title : Personalized and precision oncology as a unique avenue to have the healthcare model renewed to secure national biosafety: to get cancer treated or cured?
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). In this sense, Personalized & Precision Oncology (PPO) is an innovative approach to cancer management and is oriented t [....] » Read More
Title : Modeling a novel SMARTer design using an optimizing diagnostic: quantitative evaluation of improved patient outcome and sample size reduction, and implications for lower clinical trial costs and facilitating registration
Floyd Taub, aiGENE, Inc., United States
Modern oncology commonly requires sequential treatment; however, trials for approval typically do not include direct testing of sequences. Adaptive trials and Sequential Multiple Assignment Randomized Trial (SMART) trials are often of approved drugs and are large, slow, complex, [....] » Read More
Title : Exploring stem cell applications in cancer treatment: A systematic bibliometric evaluation
Ahora Chehri, Johann Wolfgang Goethe-Universität Frankfurt am Main (Universität Frankfurt am Main), Germany
Purpose of the study: This study aims to analyze global research trends and emerging themes in the application of stem cell biology for cancer therapy. The intent is to map the intellectual landscape and identify key areas of focus and collaboration from 2020 to 2024. Me [....] » Read More
Title : A case report of recurrent adult-type ovarian granulosa cell tumor in a 22-year-old female: Long-term efficacy of fuzulopari combined with apatinib
Jinhua Wang, Jiangsu Cancer Hospital, China
Adult-type ovarian Granulosa Cell Tumor (AGCT) is a rare low-grade malignant sex cord-stromal tumor, accounting for 2–5% of all ovarian malignancies, with 95% of cases occurring in middle-aged women aged 45–55 years. Cases in young patients ≤25 years old are extrem [....] » Read More
Title : Targeting hypoxia inducible factor (HIF) through synergetic actions of active molecules found in some functional foods, an effective cancer therapy
Paulraj S, Chennai Snake Park Trust, India
The origin, growth and spread of various cancers follow some common regulatory paths. Although hundreds of genes are involved in this process, most of these paths are initiated and controlled by one dominant and central factor, the Hypoxia Inducible Factor 1α (HIF-1α) [....] » Read More
Title : Addressing socioeconomic inequalities in breast cancer care: A national clinical pathway proposal for Mexico
Maria Isabel Sollozo Dupont, National Institute of Perinatology Isidro Espinosa de los Reyes, Mexico
Breast cancer is a major public health issue since it is the most common cause of death from malignant neoplasms in women over 25 around the world, especially in low-income countries where death rates are higher. In Mexico, preventative efforts are made harder by the fact that sc [....] » Read More
Title : Stress induced cancer and cancer induced stress outcomes on patient psychological personality
Ramalingam K, Mediclone Biotech Research Centre, India
This study aims to investigate the profound interplay between lifestyle, environmental factors, and the psychological burden of a cancer diagnosis. While medical advancements have improved survival rates, the diagnosis frequently triggers a severe "fear psychosis," char [....] » Read More
Title : Mechanistic study on the activation of primary motor cortex (M1) in inhibiting ovarian cancer through IGLUR-mediated reversal of CD8⁺ T cell exhaustion
Dongyao Zhang, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China
Objective: Ovarian cancer (OC) immunosuppression severely limits therapeutic efficacy. While peripheral neural tumor regulation is recognized, the central nervous system's (CNS) role in modulating the tumor immune microenvironment (TIME) remains unclear. We aimed to map the p [....] » Read More
Title : Evaluation of uProcess for detection of oncogene sequences in buffer and urine by qPCR following 3-minute capture and 5-minute purification procedure
Floyd Taub, aiGENE, Inc., United States
Cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA), found in blood and urine, have firmly established themselves as key analytes for the diagnosis of various cancers and for defining therapy. Primary sequence and epigenetic markers within cfDNA are key in screening and monit [....] » Read More
Title : Integrated medical care for cancer under siddha system of Indian medicine - a science based
Anbuganapathi G, Anbu Hospital, India
In the Indian context, the Siddha system of medicine (one of the oldest traditional systems, primarily from South India) is increasingly utilized as a powerful complementary and alternative medicine (CAM) for cancer. This is one of the approved medical systems under the Ministry [....] » Read More
Title : Thin-section CT prediction of visceral pleural invasion in part-solid lung adenocarcinomas ≤3 cm: relationship-specific imaging features of pleural-attached and pleural-tag nodules
Jing Sheng, Shanghai Pulmonary Hospital, Tongji University, China
Purpose: To determine whether CT predictors of visceral pleural invasion (VPI) differ by tumor–pleural relationship in part-solid lung adenocarcinoma and to develop interpretable models for pleural-attached and pleural-tag nodules. Methods: This retrospective study include [....] » Read More
Title : Ferroptosis-independent lysosomal membrane permeabilization and autophagic dysfunction induced by curcumin in H1299 lung cancer cells
Jian Hong Lin, Hualien Tzu Chi Hospital, Taiwan
Ferroptosis is an iron-dependent form of regulated cell death characterized by excessive lipid peroxidation and oxidative damage to cellular and organelle membranes. Because lysosomes are membrane-bound organelles that are particularly susceptible to oxidative injury, ferroptosis [....] » Read More
Title : Prolonged disease control with tepotinib and local radiotherapy in an 84-year-old woman with MET exon 14-skipping metastatic NSCLC
Moganapriya, Tan Tock Seng Hospital, Singapore
Will be Updated Soon...
Title : Prolonged survival across four lines of therapy in resistant/relapsed extensive-stage small cell lung cancer with rare pancreatic metastasis
Moganapriya, Tan Tock Seng Hospital, Singapore
Will be Updated Soon...